Which Prescription Weight Loss Treatment Suits You?
Understanding Wegovy And Mounjaro As Prescription Weight Loss Solutions
Wegovy and Mounjaro represent two distinct approaches to prescription weight loss, each targeting different pathways to achieve sustainable results. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This prescription-only medicine works by slowing gastric emptying and influencing brain appetite centres, helping patients feel satisfied with reduced food intake.
Mounjaro utilises tirzepatide, a dual-action medication that activates both GIP and GLP-1 receptors for comprehensive metabolic support. Both treatments require clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity. The choice between Wegovy and Mounjaro often depends on individual response patterns, medical history, and practical considerations such as storage requirements and dosing schedules.
Wegovy And Mounjaro Pricing: Complete UK Cost Breakdown
EverydayMeds offers transparent pricing for both Wegovy and Mounjaro prescriptions, with costs starting from £79.99 for the initial 0.25mg Wegovy dose. New customers receive discount code FIRST40, whilst returning customers use DOSE25 at checkout to access these competitive rates. Our Intro Duo bundle (0.25mg and 0.5mg Wegovy) costs £169.99, providing the first two months of treatment with assured cold-chain delivery.
For maintenance therapy, the 2.4mg Wegovy dose costs £209.99, with our Ultimate Stability Trio offering three months of maintenance supply for £649.99. Mounjaro pricing follows a similar structure, allowing patients to choose the most suitable treatment based on clinical guidance rather than cost alone. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy (#9012878), ensuring pharmaceutical-grade quality and proper storage throughout the supply chain.
Clinical Evidence: Wegovy And Mounjaro Weight Loss Data
In clinical trials, Wegovy demonstrated significant weight management results, with the landmark STEP 1 trial showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions (Wilding et al., NEJM, 2021). The STEP programme also revealed sustained results, with STEP 5 maintaining approximately 15.2% weight reduction over two years of continued treatment.
Mounjaro's clinical programme demonstrated its own efficacy profile through the SURMOUNT trials, though direct comparison between Wegovy and Mounjaro results requires careful consideration due to different trial designs and patient populations. Both medications require ongoing commitment, as discontinuation studies show patients typically regain approximately two-thirds of lost weight within one year of stopping treatment.
How Wegovy Works: GLP-1 Mechanism For Weight Loss
Wegovy functions as a GLP-1 receptor agonist, essentially mimicking glucagon-like peptide-1, a hormone your intestines naturally release after eating. This mechanism triggers several weight-supportive responses: delayed gastric emptying means food stays in your stomach longer, promoting sustained fullness between meals. The medication also influences hypothalamic appetite centres in your brain, potentially reducing food cravings and the psychological drive to eat. Additionally, Wegovy may enhance insulin sensitivity and glucose metabolism, though its primary indication remains weight management rather than diabetes treatment. These combined effects typically result in patients feeling satisfied with smaller portion sizes and experiencing reduced between-meal hunger, supporting adherence to calorie-controlled eating plans.
Ordering Wegovy And Mounjaro: Complete Process Guide
Starting your prescription weight loss journey with either Wegovy or Mounjaro begins with our 3-minute online clinical assessment, designed to evaluate your suitability based on MHRA licensing criteria. Our qualified prescribers review applications within 3 working days (express 24-hour review available), assessing factors including BMI, medical history, and current medications to determine the most appropriate treatment option. Once approved, your chosen medication ships via next-day delivery using temperature-controlled, cold-chain logistics to maintain pharmaceutical integrity. The prescription-only medicine arrives with comprehensive injection guidance, dose escalation schedules, and ongoing support information. Our pharmacy team remains available throughout your treatment for medication queries, storage advice, and prescription renewals.
Storage And Practical Differences: Wegovy Vs Mounjaro
Storage requirements present a key practical difference between Wegovy and Mounjaro for many patients. Wegovy FlexTouch pens maintain stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, offering significant flexibility for travel, work schedules, and daily life management. Mounjaro provides 21 days of room temperature stability, still generous but more restrictive for extended trips or irregular routines. Both treatments require refrigerator storage (2-8°C) before first use and follow similar weekly injection schedules with mandatory dose escalation protocols. The FlexTouch delivery system used by Wegovy features intuitive operation with audible dose confirmation, whilst Mounjaro employs its own injection technology with comparable ease of use for self-administration.
Wegovy And Mounjaro: Personalised Prescription Weight Loss Matching
Selecting between Wegovy and Mounjaro requires personalised clinical evaluation rather than one-size-fits-all recommendations. Wegovy's established track record and longer market presence provides extensive real-world data, whilst Mounjaro's dual-receptor mechanism offers a different therapeutic approach that may suit patients who respond suboptimally to GLP-1-only treatments. Individual factors such as gastrointestinal tolerance, injection frequency preferences, and lifestyle considerations all influence treatment selection.
Both Wegovy and Mounjaro require the same fundamental commitment: adherence to prescribed dosing schedules, maintenance of reduced-calorie nutrition plans, and integration of regular physical activity. Your prescriber will consider your medical history, current medications, weight loss goals, and practical circumstances when recommending the most suitable option, ensuring optimal treatment outcomes whilst minimising potential complications.
Start Your Wegovy And Mounjaro Assessment Today
Both Wegovy and Mounjaro are available through EverydayMeds with transparent pricing, professional oversight, and comprehensive support throughout your weight management journey. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive rates starting from £79.99. Our clinical assessment takes just 3 minutes to complete, initiating the prescriber review process that determines your treatment eligibility and optimal medication choice. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, with next-day delivery ensuring rapid treatment commencement once approved. Remember that sustainable weight management represents a long-term commitment, and our pharmacy team provides ongoing support to maximise your treatment success with either Wegovy or Mounjaro.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
